Pure Global AI
Denmark flag

Denmark medical device registration timeline

Source-linked clocks

Danish Medicines Agency (DKMA) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) — EU MDR classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (CE certificate)MDSAP not acceptedreviewed 2026-08-29eur-lex.europa.eu
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no notified body))
MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock
0 days6-9 monthsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Denmark Medical Device Registration Process

Step-by-step DKMA registration process. Total estimated timeline: 6-9 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by DKMA. Appoint a EU Authorized Representative.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to DKMA including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

DKMA reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

0 days

In-depth technical assessment of device safety and performance. DKMA may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, DKMA issues Denmark market authorization certificate.

Summary: The Denmark medical device registration process through Danish Medicines Agency (DKMA) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
FDA 510(k)/PMANo substitute for EU MDR conformity assessment; useful as predicate documentation in the technical file
Key requirements
  • EU Authorized Representative (for non-EU manufacturers)
  • Clinical investigation decision for class I and non-invasive IIa/IIb no later than 45 days after validation (MDR Art. 70(5); § 17(3) BEK 1731/2025); substantial modifications processed in 38 days
  • Ethics committees notify DKMA within 25 days of validation for supplementary-information requests, likewise DKMA (§§ 15-16 BEK 713/2022); expert-extension notice within 7 days for invasive IIa/IIb and III
  • Distributor and specialty-retailer registration processed within 14 days of receipt (valid from the submission date)
Primary regulator sources

Reviewed 2026-08-29. End-to-end totals remain planning estimates.

Keep researching this market
View the Denmark resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against DKMA publications · full review 2026-08-29 · row IDs are stable — cite as registration-timeline:denmark:class-i